Approval · Notice of Compliance 7742 · 2006
REMICADE: Notice of Compliance 7742
Issued February 8, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7742
- Date
- February 8, 2006
- Company
- Centocor Inc.Leiden, --, Netherlands
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extended indication - treatment of patients with moderate to severe rheumatoid arthritis who have not been previously treated with methotrexate
- Therapeutic class
- Selective immunosuppressive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REMICADE | Not yet assigned | — |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL